ライフサイエンスコーパス: prenatal diagnosis

1 orders can be controlled, by counselling and prenatal diagnosis.

2 reduced ovarian complement should be offered prenatal diagnosis.

3 pregnant women, undergoing amniocentesis for prenatal diagnosis.

4 the outcome of cases with and those without prenatal diagnosis.

5 nvasive source of fetal genetic material for prenatal diagnosis.

6 Our finding will aid genetic counselling and prenatal diagnosis.

7 ed, and all postconception couples opted for prenatal diagnosis.

8 d because of a chromosomal abnormality after prenatal diagnosis.

9 rier whose partner tested negative requested prenatal diagnosis.

10 tirely through screening, 20 (91%) opted for prenatal diagnosis.

11 in these cases with obvious implications for prenatal diagnosis.

12 cells in maternal blood could revolutionize prenatal diagnosis.

13 nherited condition screening and noninvasive prenatal diagnosis.

14 tervention and, perhaps, carrier testing and prenatal diagnosis.

15 many of the economic and ethical dilemmas in prenatal diagnosis.

16 sis as compared with karyotyping for routine prenatal diagnosis.

17 culation holds great promise for noninvasive prenatal diagnosis.

18 iac defects is not significantly improved by prenatal diagnosis.

19 d ALDH7A1 gene analysis provides a means for prenatal diagnosis.

20 This finding paves the way for early prenatal diagnosis.

21 s based on age or risk for offering invasive prenatal diagnosis.

22 sis and for reliable genetic counselling and prenatal diagnosis.

23 ical CHD (41 of 86 [48%]) than in those with prenatal diagnosis (16 of 67 [24%]) (P = .003).

24 who met inclusion criteria, 532 (47%) had a prenatal diagnosis, 428 (38%) had critical CHDs, 533 (47

25 d their diagnosis for preimplantation (5) or prenatal diagnosis (5) of 12 pregnancies.

26 In general, this prenatal diagnosis allows more informed prenatal counsel

27 Prenatal diagnosis alone was not associated with improve

28 milies) were included in the study (9 with a prenatal diagnosis and 17 with a postnatal diagnosis).

29 the AJ population, potentially facilitating prenatal diagnosis and carrier detection of MSUD in this

30 n take advantage of the genetic analysis for prenatal diagnosis and carrier detection of the heredita

31 ed with control HLHS patients, regardless of prenatal diagnosis and despite successful catheter-based

32 ome in 1989-1991 that could be attributed to prenatal diagnosis and elective abortion of affected fet

33 and the effect of these factors on rates of prenatal diagnosis and elective pregnancy termination.

34 These findings indicate that prenatal diagnosis and elective termination of affected

35 The authors examined the impact of prenatal diagnosis and elective termination of neural tu

36 This study examined the effect of prenatal diagnosis and elective termination on the preva

37 , these findings should assist physicians in prenatal diagnosis and genetic counseling of parents who

38 everal fields of medicine, including cancer, prenatal diagnosis and infectious diseases.

39 everal fields of medicine, including cancer, prenatal diagnosis and infectious diseases.

40 s, psychological effects, and utilization of prenatal diagnosis and its outcomes.

41 ssessment is reviewed to show the benefit of prenatal diagnosis and management as they affect outcome

42 tiology, anatomy and embryology, the role of prenatal diagnosis and mode of delivery, and initial man

43 Of the five at-risk couples, four requested prenatal diagnosis and one requested neonatal diagnosis.

44 ilure to account for the differential use of prenatal diagnosis and pregnancy termination between low

45 Guidelines recommend that prenatal diagnosis and preimplantation genetic testing a

46 sis provides reproductive options, including prenatal diagnosis and preimplantation genetic testing,

47 vances have important implications for early prenatal diagnosis and prenatal treatment.

48 These approaches allow definitive prenatal diagnosis and represent a significant improveme

49 Prenatal diagnosis and selective abortion have been effe

50 gnosed fetuses; 2) to estimate the impact of prenatal diagnosis and subsequent elective abortion of a

51 Given its high fatality rate, prenatal diagnosis and treatment are the key.

52 All patients who had a prenatal diagnosis and underwent surgery survived, where

53 Prenatal diagnosis and/or embryo selection after genetic

54 ur patients with IEI in genetic counselling, prenatal diagnosis, and accessing appropriate therapeuti

55 l practice, facilitating genetic counseling, prenatal diagnosis, and evaluation of living-related liv

56 lasma may have implications for non-invasive prenatal diagnosis, and for improving our understanding

57 evention strategies through gamete donation, prenatal diagnosis, and genetic counseling.

58 d have ushered in an era of carrier testing, prenatal diagnosis, and prevention strategies.

59 d lead to improved molecular classification, prenatal diagnosis, and therapy of this important heredi

60 Neonatal screening for CAH and gene-specific prenatal diagnosis are now possible.

61 The benefits and harm associated with prenatal diagnosis are open to debate.

62 interpretation by individuals familiar with prenatal diagnosis, are important factors for optimal pa

63 spital of Chicago between 2015 and 2021 with prenatal diagnosis as the exposure variable.

64 anzmann thrombasthenia carrier detection and prenatal diagnosis, assays to identify single nucleotide

65 Samples from women undergoing prenatal diagnosis at 29 centers were sent to a central

66 n with both the index trisomy and subsequent prenatal diagnosis at age <30 years, the SMR was 8.0; it

67 well as reagents for conducting genome-wide prenatal diagnosis at the molecular level and for detect

68 n of new cases through carrier detection and prenatal diagnosis becomes extremely important.

69 As prenatal diagnosis becomes increasingly complex, there i

70 nsfer to uterus, pregnancy confirmation, and prenatal diagnosis by amniocentesis at 16.5 weeks' gesta

71 n single gene disorders using this method of prenatal diagnosis by enriching fetal cells from materna

72 Noninvasive prenatal diagnosis by isolation and genetic analysis of

73 h the information service was made after the prenatal diagnosis by ultrasound.

74 Prenatal diagnosis can and should be used to optimize lo

75 The cells for prenatal diagnosis can be converted into iPS cells for t

76 Accurate prenatal diagnosis can now accurately identify fetal pat

77 ysfunction was significantly associated with prenatal diagnosis, CDHSG stage, intrathoracic liver, an

78 he literature, the International Society for Prenatal Diagnosis center repository, and an internet se

79 Advances in prenatal diagnosis, combined with a better understanding

80 The associations between prenatal diagnosis, CSC HLHS volume, and mortality were

81 Patients with prenatal diagnosis demonstrated faster brain development

82 tility of these circulating nucleic acids in prenatal diagnosis, early cancer detection, and the diag

83 Parallel advances in prenatal diagnosis, fetal intervention, and hematopoieti

84 Prenatal diagnosis for chromosome abnormality is routine

85 matologic disease is a viable alternative to prenatal diagnosis for couples who wish to avoid having

86 have implications for genetic counseling and prenatal diagnosis for EBS.

87 e need not include karyotyping and can offer prenatal diagnosis for the syndrome with FISH (fluoresce

88 he yield in autism spectrum disorders and in prenatal diagnosis, for which published guidelines recom

89 Those with prenatal diagnosis had an earlier estimated gestational

90 Patients with prenatal diagnosis had lower birth weight (mean, 3184.5

91 Historically, the goal of prenatal diagnosis has been to provide an informed choic

92 and implementation of carrier detection and prenatal diagnosis has dramatically decreased the incide

93 d no difference for weight, gestational age, prenatal diagnosis, HLHS variant, associated diagnoses,

94 ch other (91%), and that women should have a prenatal diagnosis if medically indicated (91%).

95 Consequently, noninvasive prenatal diagnosis in a mother and father carrying ident

96 of MLIV to chromosome 19 will permit genetic prenatal diagnosis in affected families and will aid in

97 the basis for future genetic counseling and prenatal diagnosis in Egypt and surrounding populations.

98 d treatment of this disorder in infants, and prenatal diagnosis in families that carry a mutated gene

99 tment in newborns and genetic counseling and prenatal diagnosis in subsequent pregnancies in affected

100 r neonatal demise, which helped in providing prenatal diagnosis in subsequent pregnancies.

101 Prenatal diagnosis in the second case showed the fetus t

102 we document successful use of DNA repair for prenatal diagnosis in triplet and singleton pregnancies

103 luding two sets of conjoined twins, accurate prenatal diagnosis including definition of the great art

104 g diagnostic or therapeutic clues in cancer, prenatal diagnosis, infectious diseases or organ transpl

105 e dominated recent technological advances in prenatal diagnosis: interrogation of the fetal genome in

106 The issue of missed prenatal diagnosis is disturbing, especially when it ari

107 during the first trimester of pregnancy when prenatal diagnosis is most relevant.

108 rnal blood, which suggests that non-invasive prenatal diagnosis is possible.

109 iagnosis after birth, but its usefulness for prenatal diagnosis is still emerging.

110 One clear advantage of prenatal diagnosis is the selection of fetuses that may

111 affected pregnancy identified by traditional prenatal diagnosis is unacceptable and is applicable to

112 Finally, several recent studies suggest that prenatal diagnosis may improve neonatal outcome for fetu

113 gement of anorectal malformations, including prenatal diagnosis, newborn treatment, surgical correcti

114 al plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fe

115 ruction is a primary drawback to noninvasive prenatal diagnosis (NIPD) of monogenic disease.

116 Increases in prenatal diagnosis, observed regression of certain lesio

117 aphy for early reassurance of normality or a prenatal diagnosis of a cardiac malformation.

118 sibility of providing a new option following prenatal diagnosis of a fetus affected by a severe illne

119 Prenatal diagnosis of aortic coarctation suffers from hi

120 uccessfully used direct gene analysis in the prenatal diagnosis of Batten's disease.

121 dy was to determine the associations between prenatal diagnosis of CHD and age at surgery, and whethe

122 Reviewing the advances in prenatal diagnosis of CHD in such a rapidly developing f

123 th FE clinical data to gather information on prenatal diagnosis of CHD, indications for FE, outcomes

124 in maternal serum not only could help us in prenatal diagnosis of CHDs, but also may shed new light

125 the discovery of non-invasive biomarkers for prenatal diagnosis of CHDs.

126 Prenatal diagnosis of chromosomal abnormality requires c

127 Although prenatal diagnosis of CLMs using ultrasound and MRI has

128 tively evaluated 22 paediatric patients with prenatal diagnosis of CLMs.

129 Prenatal diagnosis of coarctation of the aorta (CoA) is

130 Prenatal diagnosis of complex congenital heart defects r

131 ally be used as a reference to assist in the prenatal diagnosis of congenital anomalies with characte

132 rdiography is being used increasingly in the prenatal diagnosis of congenital cardiac malformations i

133 ography is being used more frequently in the prenatal diagnosis of congenital cardiac malformations,

134 The relationship between the prenatal diagnosis of congenital heart defects (CHDs) an

135 with even greater demand for improvement in prenatal diagnosis of congenital heart disease (CHD) and

136 S gating is an emerging technique to support prenatal diagnosis of congenital heart disease and other

137 widely established in the United Kingdom for prenatal diagnosis of congenital heart disease.

138 The relationship of prenatal diagnosis of critical congenital heart disease

139 ave not demonstrated improved survival after prenatal diagnosis of critical congenital heart disease,

140 egislation that requires women who receive a prenatal diagnosis of Down syndrome to receive positive

141 nostic test has great potential for improved prenatal diagnosis of Down's syndrome, with the advantag

142 plification of chromosome 21 markers for the prenatal diagnosis of Down's syndrome.

143 Prenatal diagnosis of eight pregnancies with keratin gen

144 Mutation screening and prenatal diagnosis of families at risk may be expedited

145 he diagnostic accuracy and confidence of the prenatal diagnosis of fetal brain abnormalities is impro

146 MR imaging is a valuable adjunct to US for prenatal diagnosis of fetal chest masses.

147 and discuss the role of amniocentesis in the prenatal diagnosis of fetal Zika infection.

148 The use of genomic sequencing (GS) for prenatal diagnosis of fetuses with sonographic abnormali

149 Clinical advances enable the prenatal diagnosis of genetic diseases that are candidat

150 tant implications for genetic counseling and prenatal diagnosis of HI, and also provide a basis to fu

151 Efforts to improve prenatal diagnosis of HLHS and subsequent delivery near

152 Prenatal diagnosis of HLHS was associated with improved

153 Imaging tests are fundamental for the prenatal diagnosis of holoprosencephaly; the diagnostic

154 ntation for leukocyte adhesion deficiency-I; prenatal diagnosis of leukocyte adhesion deficiency-I; a

155 Thus, prenatal diagnosis of single gene disorders by recoverin

156 Newborns with prenatal diagnosis of single ventricle physiology and tr

157 mong pregnancies that are terminated after a prenatal diagnosis of the defect.

158 rt on the use of direct gene analysis in the prenatal diagnosis of this disease.

159 g the current status of counseling regarding prenatal diagnosis of trisomy 18 (T18) or trisomy 13 (T1

160 Prenatal diagnosis of trisomy 21 currently relies on ass

161 Prenatal diagnosis of trisomy 21 requires an invasive te

162 comes with prenatal diagnosis, the effect of prenatal diagnosis on brain health may reveal additional

163 and March 1999 to determine the influence of prenatal diagnosis on preoperative clinical status, outc

164 , remains very bleak.Assessing the effect of prenatal diagnosis on the outcome of structural defects

165 l center (CSC), the recommended action after prenatal diagnosis, on HLHS mortality has been poorly in

166 In any cystic lung lesion without a prenatal diagnosis, operative management to confirm path

167 ntation of basic health interventions (e.g., prenatal diagnosis, penicillin prophylaxis, and vaccinat

168 ssess attitudes toward genetics, interest in prenatal diagnosis (PND) for deafness, and preference fo

169 is applicable to indications beyond those of prenatal diagnosis, such as HLA matching to affected sib

170 Prenatal diagnosis technology development is necessary t

171 hnology have been applied more frequently to prenatal diagnosis than to fetal treatment, genetic and

172 ven limited improvement of CHD outcomes with prenatal diagnosis, the effect of prenatal diagnosis on

173 ncy in this family allowed mutation-specific prenatal diagnosis to be performed in a subsequent pregn

174 past 12 months, ranging from classification, prenatal diagnosis, treatment options, and predictors of

175 e a 6-year overview of the experience of one prenatal-diagnosis unit using a defined, unselected popu

176 igital) analytical methods in the context of prenatal diagnosis using cell free DNA for monogenic dis

177 arrier and noncarrier goats and was used for prenatal diagnosis using DNA collected from fetal fluids

178 Prenatal diagnosis was changed in some patients owing to

179 Prenatal diagnosis was offered if both parents were iden

180 First-trimester prenatal diagnosis was undertaken by chorionic villus DN

181 ermination of affected pregnancies following prenatal diagnosis, was 1.53 per 1,000 live births.

182 chorionic villus sampling that are used for prenatal diagnosis, we also showed that these cells coul

183 Indications for prenatal diagnosis were advanced maternal age (46.6%), a

184 iews and opinions of antenatal screening and prenatal diagnosis were included.

185 trasound and fetal MRI can be used to make a prenatal diagnosis, while MRI is the imaging modality of

186 advantage to A-T families since a DNA based prenatal diagnosis will be possible in families where th

187 sis or standard karyotype can be offered for prenatal diagnosis with a phenotypically normal fetus.

188 estimate the strength of the association of prenatal diagnosis with age at surgery among patients wi

189 , survival of infants was not improved after prenatal diagnosis with fetal echocardiography.

190 compared the observed number of trisomies at prenatal diagnosis with the expected numbers, given mate

191 ns such as pre-implantation and non-invasive prenatal diagnosis would benefit from the ability to cha